Abstract
Despite numerous efforts by researchers the increasing fungal infections are still a major threat to the society. To combat this dilemma several antifungal drugs have come up through extensive research. Azoles are one of the most promising antifungal agents of them. They are heterocyclic five membered organic compounds which show activity against hazardous fungal pathogens. But the growing resistance against azoles in fungal pathogens and side effects accompanied with the use of synthetic azoles has generated an urgent need to search for natural and eco-friendly azoles. The present review provides a detailed account about the structure and function of clinically important antifungal azole derivatives and some patents related to them. This article also gives a brief overview about some naturally derived antifungal azoles.
Keywords: Azole, antifungal, cytochrome P450, ergosterol, fluconazole, imidazole, ketoconazole, triazole.
The Natural Products Journal
Title:Antifungal Azole Derivatives and their Pharmacological Potential: Prospects & Retrospects
Volume: 4 Issue: 2
Author(s): Sardul S. Sandhu, Harshita Shukla, Ravindra P. Aharwal, Suneel Kumar and Shyamji Shukla
Affiliation:
Keywords: Azole, antifungal, cytochrome P450, ergosterol, fluconazole, imidazole, ketoconazole, triazole.
Abstract: Despite numerous efforts by researchers the increasing fungal infections are still a major threat to the society. To combat this dilemma several antifungal drugs have come up through extensive research. Azoles are one of the most promising antifungal agents of them. They are heterocyclic five membered organic compounds which show activity against hazardous fungal pathogens. But the growing resistance against azoles in fungal pathogens and side effects accompanied with the use of synthetic azoles has generated an urgent need to search for natural and eco-friendly azoles. The present review provides a detailed account about the structure and function of clinically important antifungal azole derivatives and some patents related to them. This article also gives a brief overview about some naturally derived antifungal azoles.
Export Options
About this article
Cite this article as:
Sandhu S. Sardul, Shukla Harshita, Aharwal P. Ravindra, Kumar Suneel and Shukla Shyamji, Antifungal Azole Derivatives and their Pharmacological Potential: Prospects & Retrospects, The Natural Products Journal 2014; 4 (2) . https://dx.doi.org/10.2174/221031550402141009100632
DOI https://dx.doi.org/10.2174/221031550402141009100632 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders
Central Nervous System Agents in Medicinal Chemistry Editorial [Is Drug Safety Dangerous?]
Current Drug Safety Special Features of Gram-Positive Bacterial Eradication by Photosensitizers
Recent Patents on Anti-Infective Drug Discovery Recent Developments in the Synthesis and Biological Activity of Muramylpeptides
Current Medicinal Chemistry Recent Advances in the Discovery of Novel Anti-Herpetic Agents from Chinese Herbal Medicines
Current Organic Chemistry Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach
Current Pharmaceutical Design Blood-Brain Barrier Transport of Cytokines: A Mechanism for Neuropathology
Current Pharmaceutical Design Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)
CNS & Neurological Disorders - Drug Targets The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System
Current Neuropharmacology Withdrawal Notice: Evaluation of Clinical Profile, Diagnostic Tests, And Prognosis of Crypto-coccal Meningitis in HIV Infected Patients in Western India
Infectious Disorders - Drug Targets Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design The Quantitative Structure Activity Relationships for Predicting HIV Protease Inhibition by Substituted Fullerenes
Letters in Drug Design & Discovery Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation
Current Alzheimer Research Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy
Current Medicinal Chemistry Can Mycobacterial Genomics Generate Novel Targets as Speed-Breakers Against the Race for Drug Resistance
Current Pharmaceutical Design Possible Protecting Role of TNF-α in Kainic Acid-induced Neurotoxicity Via Down-Regulation of NFκB Signaling Pathway
Current Alzheimer Research The Origin of Lentivirus Research: Maedi-Visna Virus
Current HIV Research Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Current Drug Safety Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Current Pharmaceutical Design